The HPV Primary Screening Pilot will explore the use human papillomavirus (HPV) testing as a first-line cervical screening method.
HPV infections play a crucial role in the aetiology of cervical lesions. Various molecular assays have been developed to detect HPV. HPV DNA testing is already being used for the management of cervical disease.
Human papilloma virus is now recognised as the major cause of cervical cancer. Although other factors like smoking can contribute to your risk, the general consensus is, the presence of a high-risk type of human papilloma virus is necessary.
There is a clear association between certain types of wart (human papilloma) viruses and the development of abnormal smear tests, and ultimately an increased risk of cervical cancer.